Therese Liechtenstein

Investment Director at 4BIO Capital

Speaker

Therese Liechtenstein is an Investment Director at 4BIO Capital, where she leads investments in early-stage therapeutics companies. 4BIO Capital is an international venture capital firm focused on investing in advanced therapies and emerging modalities, to unlock the treatments of the future. Previously, Therese worked at M Ventures, the corporate venture arm of EMD Serono. Prior to that, she managed strategic projects for the Healthcare business of EMD Serono. Therese holds a PhD in Immuno-Oncology from University College London, an MSc in Biomedical Sciences from the University of Amsterdam, and a BA in Biology and Business studies from New York University.